Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  This percentage is calculated based upon 51,899,648 ordinary shares of the Issuers common stock outstanding as of April 24th, 2026, based on the DEF 14A Filing on June 29th, 2026. However, as more fully described in Item 4, the securities reported in rows 6, 8 and 9 show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8 and 9. (6) 5,169,501 shares of Common Stock 2,941,180 shares of Common Stock issuable upon exercise of warrants 4,802,501 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person:  (6) 5,169,501 shares of Common Stock 2,941,180 shares of Common Stock issuable upon exercise of warrants 4,802,501 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person:  (6) 5,169,501 shares of Common Stock 2,941,180 shares of Common Stock issuable upon exercise of warrants 4,802,501 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person:  (6) 5,169,501 shares of Common Stock 2,941,180 shares of Common Stock issuable upon exercise of warrants 4,802,501 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G



 
Rosalind Advisors, Inc.
 
Signature:Steven Salamon
Name/Title:President
Date:08/12/2026
 
SALAMON STEVEN A J
 
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:08/12/2026
 
Aharon Gil
 
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:08/12/2026
 
Rosalind Master Fund L.P.
 
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:08/12/2026
Schedule 13G

 


Exhibit A

Joint Filing Agreement

 

The undersigned hereby agree that this Statement on Schedule 13G/A with respect to the beneficial ownership of shares of Common Stock of Talphera, Inc. is filed jointly on behalf of each of them.

 

 

Rosalind Advisors, Inc.

By: _____________________________

Name: Steven Salamon

Title: President

 

Rosalind Master Fund L.P.

By: _____________________________

Name: Mike McDonald

Title: Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)

 

By: _____________________________

Name: Steven Salamon


 

NYC#: 139632.2